Cognitive-Behavioral Therapy With Exercise Training in Adolescent Females With Elevated Depression Symptoms
- Disease/Condition
- Depression
- Drug/Device/Intervention
- Cognitive-Behavioral Therapy
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Doaa Tammam Atia
- Funder
- Suez University
- Location
- Suez, Egypt
- Phase
- N/A
- Start date
- Dec 25, 2023
- End date
- Mar 01, 2024
- Enrollment
- 60 participants
Center for Epidemiological Studies Depression Scale for Children (CES-DC),
PURPOSE: To Study the Effect of Cognitive-behavioral therapy combined with exercise training
 in adolescent females with elevated depression symptoms
 
 BACKGROUND: Teenagers are more likely than any other age group to experience psychological
 issues due to depression, Adolescents have gotten active attention from society for their
 mental health difficulties since they are a high-level reserve talent stratum in society.
 Adolescent depression rates have increased in recent years, and silent killers are preying
 on them. Teenagers are more likely than any other age group to experience psychological
 issues due to depression, Adolescents have gotten active attention from society for their
 mental health difficulties since they are a high-level reserve talent stratum in society.
 Adolescent depression rates have increased in recent years, and silent killers
 
 RESEARCH QUESTION: Is there is an effect of exercise on depression in adolescent girls.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06281288
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06281288 through Pure Global AI's free database. This phase not specified trial is sponsored by Doaa Tammam Atia and is currently Enrolling by invitation. The study focuses on Depression. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.